MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-31-2025
Integra LifeSciences Holdings Corporation DPO Ratio 2011-2026 | IART
Annual DPO Ratio Integra LifeSciences Holdings Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 43.8 | 54 | 50.9 | 35.5 | 58.8 | 73.1 | 48.6 | 78.8 | 30.4 | 38.9 | 35.2 | 55.4 | 42.7 | 33.7 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 78.8 | 30.4 | 48.6 |
Quarterly DPO Ratio Integra LifeSciences Holdings Corporation
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 40.7 | 41 | 46.8 | 47.9 | 52.9 | 53.8 | 55.7 | 66.3 | - | 24.8 | 27.2 | 48.1 | - | 39.5 | 38.3 | 36.3 | - | 37 | 47.2 | 57.3 | - | 72.3 | 71.8 | 66.9 | - | 48.5 | 50.5 | 53.8 | - | 84.3 | 86.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 86.6 | 24.8 | 51.8 |
DPO Ratio of other stocks in the Medical devices industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BIOLASE
BIOL
|
66.7 | - | -13.19 % | $ 166 K |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
81.3 | - | - | $ 1.77 B | USA |
 |
AdaptHealth Corp.
AHCO
|
43.9 | $ 13.08 | 2.19 % | $ 1.77 B | USA |
 |
Allied Healthcare Products
AHPI
|
23.1 | - | 3.58 % | $ 2.21 M | USA |
 |
Avinger
AVGR
|
45.5 | - | -20.74 % | $ 369 K | USA |
 |
Lianluo Smart Limited
LLIT
|
10.5 | - | 24.59 % | $ 44.8 M |  China |
 |
Axonics Modulation Technologies
AXNX
|
40.1 | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
286 | - | 1.37 % | $ 20.5 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
224 | - | -5.86 % | $ 30.6 M | USA |
 |
Cardiovascular Systems
CSII
|
81.8 | - | 0.15 % | $ 844 M | USA |
 |
Conformis
CFMS
|
50.4 | - | - | $ 16.4 M | USA |
 |
Dynatronics Corporation
DYNT
|
52.2 | - | 14.99 % | $ 929 K | USA |
 |
Cytosorbents Corporation
CTSO
|
107 | $ 0.61 | -2.58 % | $ 38 M | USA |
 |
Apollo Endosurgery
APEN
|
63.6 | - | - | $ 475 M | USA |
 |
EDAP TMS S.A.
EDAP
|
40.6 | $ 3.22 | - | $ 121 M |  France |
 |
ClearPoint Neuro
CLPT
|
33.2 | $ 11.21 | -4.84 % | $ 317 M | USA |
 |
Globus Medical
GMED
|
33.1 | $ 93.7 | -1.24 % | $ 12.7 B | USA |
 |
Eargo
EAR
|
124 | - | - | $ 10.2 M | USA |
 |
CryoLife, Inc.
CRY
|
41.1 | - | -4.14 % | $ 702 M | USA |
 |
Electromed
ELMD
|
47.8 | $ 26.0 | -1.48 % | $ 220 M | USA |
 |
Second Sight Medical Products
EYES
|
29.6 | - | -0.97 % | $ 54.4 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
204 | - | 1.15 % | $ 34.5 M | USA |
 |
Helius Medical Technologies
HSDT
|
362 | $ 2.12 | -1.85 % | $ 1.29 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
131 | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
83.1 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
48.6 | - | - | $ 111 M |  Canada |
 |
Butterfly Network
BFLY
|
51.3 | $ 5.48 | 2.81 % | $ 1.16 B | USA |
 |
Intersect ENT, Inc.
XENT
|
72.8 | - | - | $ 955 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
79.4 | $ 15.82 | -2.29 % | $ 371 M | USA |
 |
Delcath Systems
DCTH
|
56 | $ 10.84 | - | $ 388 M | USA |
 |
LivaNova PLC
LIVN
|
68 | $ 63.41 | -1.23 % | $ 3.46 B |  Britain |
 |
IRIDEX Corporation
IRIX
|
71.9 | $ 1.08 | 1.89 % | $ 18.3 M | USA |
 |
LENSAR
LNSR
|
146 | $ 5.21 | 2.36 % | $ 62.3 M | USA |
 |
CONMED Corporation
CNMD
|
57.3 | $ 37.87 | -1.23 % | $ 1.18 B | USA |
 |
Inspire Medical Systems
INSP
|
103 | $ 55.07 | -2.2 % | $ 1.62 B | USA |
 |
Pulmonx Corporation
LUNG
|
60.4 | $ 1.28 | 0.79 % | $ 52.1 M | USA |
 |
Integer Holdings Corporation
ITGR
|
28.9 | $ 85.35 | -0.78 % | $ 2.96 B | USA |
 |
Invacare Corporation
IVC
|
75.6 | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
58.1 | $ 83.46 | -0.94 % | $ 48.8 B | USA |
 |
MiMedx Group
MDXG
|
54.8 | $ 3.34 | -2.62 % | $ 494 M | USA |
 |
NanoVibronix
NAOV
|
58.2 | - | - | $ 1.08 M | USA |
 |
Nevro Corp.
NVRO
|
61.7 | - | - | $ 217 M | USA |
 |
Myomo
MYO
|
34.8 | $ 0.83 | 0.8 % | $ 34.7 M | USA |
 |
Cutera
CUTR
|
57.2 | - | -10.19 % | $ 1.99 M | USA |
 |
Natus Medical Incorporated
NTUS
|
52.1 | - | 1.94 % | $ 1.05 B | USA |
 |
Orthofix Medical
OFIX
|
76.3 | $ 12.32 | -0.24 % | $ 488 M |  Curacao |